iatroX logo
brainstormaskiatroXquizcpdknowledge centrehow it worksaboutblog
Knowledge Centre / Adult-Onset Still's Disease (AOSD)

Adult-Onset Still's Disease (AOSD)

Overview and management.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 30 August 2025
Rheumatology

Clinical Guidelines

NHS England Clinical Commissioning Policy: Tocilizumab for the treatment of adult onset Still’s disease (AOSD)
National
NICE technology appraisal guidance [TA685]: Anakinra for treating Still's disease
National

Recent iatroX Q&As

  • Which laboratory tests are most useful in confirming a diagnosis of Adult-Onset Still's Disease?Updated: 8/17/2025
  • What are the recommended first-line treatment options for managing Adult-Onset Still's Disease in adults?Updated: 8/17/2025
  • When should I consider referring a patient with suspected Adult-Onset Still's Disease to a rheumatologist?Updated: 8/17/2025
ask iatroX
privacy terms faq
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play